About Us
Exactics is a Chicago-based startup that develops rapid diagnostic tools for underrepresented infectious diseases to expedite at-home and clinical diagnoses, subsequently improving treatment plans and long-term health outcomes. Exactics has developed QuickLyme, a patented 15-minute at-home test for Lyme disease and has developed and patented an adaptable test platform, Proteusâș, using competitive lateral flow immunoassay technology.
Our Story
After watching his best friend suffer from the detrimental effects of
Lyme Disease, Julian Kage, Founder and CEO of Exactics, set out to
figure out why his friend had not received help until suffering
irreversible damage and persistent chronic symptoms. At only 12 years
old, Julian self studied to become an expert on Lyme Disease,
infectious disease diagnostics, and specifically lateral flow assays.
In 2017, Julian developed the QuickLyme technology to help others like
his friend. Julian presented his technology at the National Invention Convention
and Entrepreneurship Exposition, where he won funding from the Henry Ford
Foundation to patent his work. In 2021, Julian founded Exactics before
continuing his medical education at the University of Chicago. Then in
2023, he established a co-founding team of like-minded peers from the University
of Chicago and Tulane University to help execute the shared vision to improve
health outcomes globally.
Our team
Julian Kage
Chief Executive Officer
Dylan Murray
Chief Operating Officer
Zachary Sarmoen
Chief Financial Officer
Maxwell Almeida
Chief Technology Officer
Sean Greeby
Chief Scientific Officer
Miranda Thomson
Business Intern
John Trevino
Research Intern
Dylan Martin
Technology Intern
Advisory Board
Our advisory board includes a medical and biotech entrepreneurship expert from Harvard Medical School, a corporate finance expert from Cambridge University and the University of Chicago, an infectious disease expert from Lagos State University, and an infectious disease expert from the University of Ibadan.